[HTML][HTML] Lesson of the month (1): Cabergoline–'I eat funny on that'

VS Premaratne, I Saeger, BK MacDonald - Clinical medicine, 2014 - ncbi.nlm.nih.gov
We present the case of a patient treated for hyperprolactinaemia with weekly doses of
cabergoline for 12 years. Over this time she had suffered from binge eating and compulsive …

[HTML][HTML] Impulse Control Disorders with Short-term Use of Cabergoline in Macroprolactinomas: A Prospective Study with a Brief Review of Literature

G Sanjan, L Das, CK Ahuja, S Dhandapani… - Neurology …, 2023 - journals.lww.com
Impulse control disorders (ICDs) are less-emphasized adverse effects of dopamine agonists.
Evidence on prevalence and predictors of ICDs in patients with prolactinomas is limited and …

Treatment with cabergoline is associated with weight loss in patients with hyperprolactinemia

J Korner, J Lo, PU Freda, SL Wardlaw - Obesity, 2003 - search.proquest.com
To the Editor: Cabergoline is a new long-acting dopamine receptor agonist that is used for
the treatment of hyperprolactinemic disorders. Binding studies show that cabergoline has …

[HTML][HTML] Binge Eating and Compulsive Buying During Cabergoline Treatment for Prolactinoma: A Case Report

AC Correa e Castro, AA de Araujo, MC Botelho… - Frontiers in …, 2022 - frontiersin.org
Prolactinomas are the most prevalent functional pituitary adenomas. They are usually
treated clinically with dopamine agonists. The most widely used and suitable drug is …

[PDF][PDF] Pathological gambling and hypersexuality in cabergoline-treated prolactinoma

H Falhammar, JY Yarker - Medical journal of Australia, 2009 - mja.com.au
The patient had a tender increase of the right breast tissue. His testes appeared nor mal. He
had markedly elevated prolactin levels (410 μg/L; reference range [RR],< 15 μg/L) and …

[PDF][PDF] Cabergoline-induced mania in a patient of pituitary microadenoma

S Mohapatra, MR Nayak - Indian journal of psychological …, 2017 - journals.sagepub.com
Cabergoline, a dopamine agonist agent, is commonly used in the treatment of
hyperprolactinemia, Parkinson's disease, restless leg syndrome, and antipsychotic-induced …

[HTML][HTML] Cabergoline associated with first episode mania

YT Harris, AZ Harris, JM Deasis, SJ Ferrando… - …, 2012 - ncbi.nlm.nih.gov
Cabergoline Associated with First Episode Mania - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

[CITATION][C] Cabergoline: an advance in dopaminergic therapy

JS Bevan, JRE Davis - Clinical endocrinology, 1994 - Wiley Online Library
Medical treatment with dopamine agonists is now well established as primary therapy for
patients with prolactinomas of all sizes (Thorner et al., 1974; Crosignani & Ferrari, 1990; …

[PDF][PDF] Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma.

M Davie - The Journal of neuropsychiatry and clinical …, 2007 - Am Neuropsych Assoc
The patient was a previously well woman with no psychiatric history and no previous history
of gambling. She was diagnosed with a pituitary prolactinoma at 25 years of age after …

Pathological gambling associated with cabergoline in a case of recurrent depression.

J Miura, A Kikuchi, A Fujii, T Tateishi… - Drug Discoveries & …, 2009 - search.ebscohost.com
Pathological gambling has been described frequently in patients with Parkinson disease or
other movement disorders who were treated with dopamine agonists. Here, we report a …